POAI Predictive Oncology Inc

USD 2.78 0.11 4.11985
Icon

Predictive Oncology Inc (POAI) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.78

+0.11 (+4.12)%

USD 0.01B

9.92K

N/A

N/A

Icon

POAI

Predictive Oncology Inc (USD)
COMMON STOCK | NSD
USD 2.78
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01B

N/A

USD 2.78

Predictive Oncology Inc (POAI) Stock Forecast

N/A

Based on the Predictive Oncology Inc stock forecast from 0 analysts, the average analyst target price for Predictive Oncology Inc is not available over the next 12 months. Predictive Oncology Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Predictive Oncology Inc is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Predictive Oncology Inc’s stock price was USD 2.78. Predictive Oncology Inc’s stock price has changed by +7.75% over the past week, -14.72% over the past month and -50.36% over the last year.

No recent analyst target price found for Predictive Oncology Inc
No recent average analyst rating found for Predictive Oncology Inc

Company Overview Predictive Oncology Inc

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molec...Read More

2915 Commers Drive, Eagan, MN, United States, 55121

31

December

USD

USA

Adjusted Closing Price for Predictive Oncology Inc (POAI)

Loading...

Unadjusted Closing Price for Predictive Oncology Inc (POAI)

Loading...

Share Trading Volume for Predictive Oncology Inc Shares

Loading...

Compare Performance of Predictive Oncology Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for POAI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Predictive Oncology Inc (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG
Intuitive Surgical Inc +2.47 (+0.62%) USD139.68B 78.19 61.43

ETFs Containing POAI

Symbol Name POAI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Predictive Oncology Inc (POAI) Stock

Stock Target Advisor's fundamental analysis for Predictive Oncology Inc's stock is Bearish.

Unfortunately we do not have enough data on POAI's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on POAI's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on POAI's stock to indicate if its overvalued.

The last closing price of POAI's stock was USD 2.78.

The most recent market capitalization for POAI is USD 0.01B.

Unfortunately we do not have enough analyst data on POAI's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Predictive Oncology Inc's stock.

As per our most recent records Predictive Oncology Inc has 31 Employees.

Predictive Oncology Inc's registered address is 2915 Commers Drive, Eagan, MN, United States, 55121. You can get more information about it from Predictive Oncology Inc's website at https://www.predictive-oncology.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...